Myocardial perfusion by contrast-enhanced echocardiography and dynamic contrast-enhanced MR imaging

Acta Radiologica, Supplement

Volumn 38, Issue 412, 1997, Pages 79-84

  Lombard, M ^a   Rovai, D ^a   Rinck, P A ^b   L'Abbate, A ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF MONS   (Belgium)

Author keywords

Echocardiography; MR contrast agents; Myocardial perfusion

Indexed keywords

CONTRAST MEDIUM;

CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; HEART; HISTOLOGY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

CONTRAST MEDIA; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; HEART; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0005222007     PISSN: 03655954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. COTTER B., DUONG A., OHMORI K. et al.: Evaluation of QW7437, a third generation ultrasonic contrast agent capable of myocardial opacification. Dose-response characteristics, time-course, hemodynamic response and detection of coronary occlusion. Circulation 94 (1996), 8.
2. DE Roos A., VAN ROSSUM A. C., VAN DER WALL E. E. et al.: Reperfused and non-reperfused myocardial infarction. Potential of gadolinium-DTPA-enhanced MR imaging. Radiology 172 (1989), 717.
3. DITTRICH H. C., BALES G. L., KUVELAS T. et al.: Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J. Am. Soc. Echocardiogr. 8 (1995), 465.
4. FEINSTEIN S. B., CHEIRIF J., TEN GATE F. J. et al.: Safety and efficacy of a new transpulmonary contrast agent. Initial multicenter clinical results. J. Am. Coll. Cardiol. 16 (1990), 316.
5. GRAYBURN P. A., ERICKSON J. M., ESCOBAR J. et al.: Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion. Identification of myocardial risk area and infarct size in the canine model of ischemia. J. Am. Coll. Cardiol. 26 (1995), 1340.
6. KELLER M. W., FEINSTEIN S. B. & WATSON D. D.: Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent. An experimental evaluation. Am. Heart J. 114 (1987), 570.
7. KITAMURA J., MURAKAMI Y., SHIMADA T. et al.: Reversibility of ischemic myocardial injury can be predicted by gadolinium-DTPA enhanced magnetic resonance imaging after perfusion. JACC 114 A (1995), 929.
8. LOMBARDI M., JONES R. A., WESTBY J. et al.: Relative quantitation of myocardial perfusion by MRI and intravenous iron based contrast in the open chest pig. Circulation 94 (1996), 1.
9. LOMBARDI M., KVAERNESS J., SOMA J. et al.: Relationship between funcion, perfusion and contractile reserve early after myocardial infarction. A dynamic magnetic resonance and stress echocardiographic study in man. JACC 12 A (1995), 901.
10. MATHEIJSSEN N. A. A., LOUWERENBURG H. W., VAN RUGGE F. P. et al.: Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole sestamibi SPECT for detection of perfusion abnormalities in patients with single vessel coronary artery disease. Assessment by quantitative model fitting. Magn. Reson. Med. 35 (1996), 221.
11. McNAMARA M. T., TSCHOLAKOFF D., REVEL D. et al.: Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 158 (1986), 765.
12. MULVAOH S. L., FOLEY D. A., AESCHBAKER B. C. & KLARICH K. K.: Second harmonic contrast echocardiography enables non-invasive evaluation of coronary blood flow. Eur. Heart J. 16 (1995), Suppl., p. 393.
13. MULVAGH S. L., FOLEY D. A., AESCHBACHER B. C. et al.: A new intravenous perfluorochemical echocardiographic contrast agent, Imagent. US imaging characteristics and hemodynamic profile. (Abstract p. 345.) J. Am. Soc. Echocardiogr. 8 (1995).
14. PESHOCK R. M., MALLOY C. R., BUJA L. M. et al.: Magnetic resonance imaging of acute myocardial infarction. Gadolinium diethylenetriamine-pentaacetic acid as a marker of reperfusion. Circulation 74 (1986), 1434.
15. PORTER T. R. & XIE F.: Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight soluble gases. J. Am. Coll. Cardiol. 25 (1995), 509.
16. PORTER T. R. & XIE F.: Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanism. Circulation 92 (1995), 2391.
17. ROVAI D., LUBRANO V., VASSALLE C. et al.: Detection of myocardial perfusion deficits by intravenous administration of the ultrasonic contrast agent BR1. Circulation 92 (1995), Supp). 1, p. 1.
18. SAED M., WENDLAND M. F., MASUI T. et al.: Myocardial infarction on T1 and susceptibility-enhanced MRI. Evidence for loss of compartmentalization media. Magn. Reson. Med. 31 (1994), 31.
19. SCHLIEF R., STAKS T., MAHLER M. et al.: Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. J. Am. Soc. Echocardiogr. 7 (1994), 61.
20. SMITH M., KWAN O. L., NISSEN S. et al.: Left heart opacification after peripheral venous injection. Pulmonary transmission of ZK44012, a new contrast agent. Circulation 72 (1985),57.
21. SUTHERLAND G. R., GRAUER S. E., MORAN C. et al.: Aerosomes MRX 115 echo contrast agent demonstrates myocardial opacification after intravenous injection in humans, without significant side effects, in a phase I clinical trial. Circulation 92 (1995), Suppl., p. 2213.
22. TORHEIM G., LOMBARDI M. & RINCK P. A.: An independent software system for the analysis of dynamic MR images. Acta Radiol. 38 (1997), 165.
23. VILLANEUVA F. S., GLASHEEN W. P., SKLENAR J. et al.: Successful and reproducible myocardial opacification during two-dimensional echocardiography from right atrial injection of contrast. Circulation 85 (1992), 1447.
24. Voci P., BILOTTA F., MERIALDO P. et al.: Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles. A transesophageal echocardiography dipyridamole study. J. Am. Soc. Echocardiogr. 7 (1994), 337.
25. WILKE N., KROLL K., MERKLE H. et al.: Regional myocardial blood volume and flow. First pass MR imaging with polylysine-gadolinium-DTPA. J. Magn. Reson. Imaging 5 (1995), 227.
26. WILKE N., SIMM J., ZHANG J. et al.: Contrast-enhanced first pass myocardial perfusion imaging. Correlation between myocardial blood flow in dogs at rest and during hyperaemia. Magn. Reson. Med. 29 (1993), 485.